← Back to Clinical Trials
Recruiting NCT05088746

NCT05088746 Comparing Different Timings for Periodontal Re-evaluation After Non-surgical Periodontal Therapy (NSPT)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05088746
Status Recruiting
Phase
Sponsor University of Parma
Condition Periodontitis
Study Type OBSERVATIONAL
Enrollment 52 participants
Start Date 2021-06-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Non-surgical periodontal therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 52 participants in total. It began in 2021-06-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a prospective cohort study that aims to describe the difference in terms of percentage of closed pockets (PPD \<5 mm and no BOP) when performing the periodontal re-evaluation at 3-4, 6-8 and 12 months. Fifty-two, ≥18-year old, otherwise healthy, periodontitis patients will be recruited at Centro di Odontoiatria, Università di Parma.

Eligibility Criteria

Inclusion Criteria: * Systemically healthy males and females ≥18 years old * Willingness to read and sign a copy of the Informed Consent Form after reading the Patient Information Sheet, and after the nature of the study has been fully explained * Clinical evidence of periodontitis, defined as the presence of interdental clinical attachment loss detectable at ≥2 non-adjacent teeth or buccal or oral clinical attachment loss ≥3mm with pocketing \>3 mm detectable at ≥2 teeth (Tonetti et al., 2018) * Not having received subgingival instrumentation within the previous 12 months Exclusion Criteria: * Medical history that includes serious medical conditions or transmittable diseases (e.g. serious cardiovascular disease, organ transplant, renal failure, AIDS, viral etc.). * Antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam. * In treatment with drugs that induce gingival overgrowth * History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures * History of alcohol or drug abuse. * Self-reported pregnancy or lactation (this criterion is due to oral tissue changes related to pregnancy and nursing, which can affect interpretation of study results). * Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or investigational product administration or may interfere with the interpretation of trial results and, in the judgement of the investigator, would make the subject inappropriate for entry into this trial.

Contact & Investigator

Central Contact

Elena Calciolari, DDS, MS, PhD

✉ elena.calciolari@unipr.it

📞 0521 033640

Frequently Asked Questions

Who can join the NCT05088746 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Periodontitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05088746 currently recruiting?

Yes, NCT05088746 is actively recruiting participants. Contact the research team at elena.calciolari@unipr.it for enrollment information.

Where is the NCT05088746 trial being conducted?

This trial is being conducted at Parma, Italy.

Who is sponsoring the NCT05088746 clinical trial?

NCT05088746 is sponsored by University of Parma. The trial plans to enroll 52 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology